Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
29
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
7:30 AM - HLTH 2025
18
19
20
22
23
24
25
26
27
28
29
30
31
1
2
12:00 AM - NextGen UGM 2025
TigerConnect + eVideon Unite Healthcare Communications
2025-09-30    
10:00 am
TigerConnect’s acquisition of eVideon represents a significant step forward in our mission to unify healthcare communications. By combining smart room technology with advanced clinical collaboration [...]
Pathology Visions 2025
2025-10-05 - 2025-10-07    
8:00 am - 5:00 pm
Elevate Patient Care: Discover the Power of DP & AI Pathology Visions unites 800+ digital pathology experts and peers tackling today's challenges and shaping tomorrow's [...]
AHIMA25  Conference
2025-10-12 - 2025-10-14    
9:00 am - 10:00 pm
Register for AHIMA25  Conference Today! HI professionals—Minneapolis is calling! Join us October 12-14 for AHIMA25 Conference, the must-attend HI event of the year. In a city known for its booming [...]
HLTH 2025
2025-10-17 - 2025-10-22    
7:30 am - 12:00 pm
One of the top healthcare innovation events that brings together healthcare startups, investors, and other healthcare innovators. This is comparable to say an investor and [...]
Federal EHR Annual Summit
2025-10-21 - 2025-10-23    
9:00 am - 10:00 pm
The Federal Electronic Health Record Modernization (FEHRM) office brings together clinical staff from the Department of Defense, Department of Veterans Affairs, Department of Homeland Security’s [...]
NextGen UGM 2025
2025-11-02 - 2025-11-05    
12:00 am
NextGen UGM 2025 is set to take place in Nashville, TN, from November 2 to 5 at the Gaylord Opryland Resort & Convention Center. This [...]
Events on 2025-10-05
Events on 2025-10-12
AHIMA25  Conference
12 Oct 25
Minnesota
Events on 2025-10-17
HLTH 2025
17 Oct 25
Nevada
Events on 2025-10-21
Events on 2025-11-02
NextGen UGM 2025
2 Nov 25
TN

Events

Latest News

AI model enhances oropharyngeal cancer prediction

Applying artificial intelligence (AI) in the nodal metastasis microenvironment may enhance accuracy in predicting extracapsular nodal extension (ECE) for oropharyngeal carcinoma patients, as revealed in a poster at the 2024 Symposium on Multidisciplinary Head and Neck Cancers by the American Society for Radiation Oncology (ASTRO).

Utilizing support vector machine (SVM) with linear discriminant analysis (LDA), incorporating 24 radiomics features while eliminating correlated ones, achieved a 75.5% accuracy (0.76 area under the curve [AUC]) in ECE detection. Moreover, SVM/LDA demonstrated a 72.6% accuracy (0.61 AUC, 0.41) when utilizing 10 topological features. The accuracy improved to 81.1% (0.8 AUC) by combining both radiomic and topological features in the analysis.

Applying support vector machine (SVM) with linear discriminant analysis (LDA), utilizing 51 radiomics features and eliminating correlated ones, achieved an 84.9% accuracy (0.87 area under the curve [AUC]) in ECE detection. The combination of SVM and LDA using 33 topographical data analysis (TDA) features yielded an accuracy of 80.2% (0.79 AUC). The integration of both radiomics and TDA features in the analysis significantly enhanced the accuracy of ECE detection to 90.6% (0.93 AUC).

Upon incorporating human papillomavirus (HPV) status into the multi-machine learning model, researchers observed an elevated accuracy of 92.5% (AUC, 0.95). This approach yielded a true-positive rate of 100% and a true-negative rate of 90%.

Applying artificial intelligence for the analysis of the nodal metastasis microenvironment enhances the accuracy of predicting extracapsular extension (ECE) in patients with oropharyngeal cancer,” commented Dr. Annie W. Chan, an oncologist and radiation oncologist. She holds positions as the Director of the Head and Neck Radiation Oncology Research Program and the Head and Neck Service at Massachusetts General Hospital. The authors underscored the importance of validating these findings with datasets from multiple institutions.

The authors highlighted that the approach of reducing treatment intensity for individuals with early-stage oropharyngeal carcinoma typically includes performing surgery with or without adjuvant radiotherapy, while excluding concurrent chemotherapy. However, the identification of nodal extracapsular extension (ECE) through pathology indicated the need for postoperative chemotherapy in this specific group.

In a decision-making system guided by radiologists, the evaluation of extracapsular extension (ECE) in patients involved CT imaging followed by visual assessment by radiologists, influencing subsequent treatment decisions. Individuals with ECE-positive disease underwent a combination of radiation and chemotherapy, while those with ECE-negative disease opted for either transoral surgery or neck dissection. Subsequently, patients with consistently ECE-negative findings proceeded with radiotherapy, while those diagnosed with ECE-positive disease were directed toward a treatment approach involving both radiation and chemotherapy.

The researchers found that utilizing clinical annotations or CT imaging with machine learning and deep learning algorithms to predict extracapsular extension (ECE) yielded AUCs ranging from 0.58 to 0.85, a performance level they deemed suboptimal.

The investigators suggested that both involved nodes and the peritumoral environment in patients with oropharyngeal cancer collectively played a role in determining the presence of ECE. They conducted a study to assess whether employing AI-based tools in the microenvironment of nodal metastases could enhance their ability to predict ECE.

In total, 171 patients diagnosed with newly resectable oropharyngeal carcinoma underwent upfront transoral robotic surgery and neck dissection at Massachusetts General Hospital and Massachusetts Eye and Ear Infirmary between 2016 and 2022. Preoperative high-resolution CT scans were conducted for each patient, and experienced head and neck radiologists determined the absence of extracapsular extension (ECE). Furthermore, the pathology of surgical specimens, including the presence and extent of ECE, was assessed by a head and neck pathologist.

The investigators characterized the perinodal microenvironment as the stromal tissues surrounding the nodes as identified through preoperative CT imaging. Radiomics and topological features were also extracted from the nodal and perinodal microenvironment to create predictions for detecting ECE.